登录 | 注册    关注公众号  
微信公众号
搜索
 > 【ADORA2A】

ADORA2A信息

英文名称:Adenosine A2a receptor
中文名称:腺苷A2a受体
靶点别称:Adenosine receptor A2a,ADORA2A,Adenosine A2a Receptor,ADORA2,Adenosine Receptor Subtype A2a,A2aR,RDC8,Receptor, Adenosine A2A
上市药物数量:45
临床药物数量:21
最高研发阶段:批准上市

ADORA2A产品列表

货号 物种 产品描述 蛋白结构 纯度 活性
ADA-H52D3
Human
Human ADORA2A Protein, Flag,His Tag (Detergent)
ADA-H52P4
Human
Human ADORA2A Full Length Protein (VLP)
ACRO质量管理体系
 
评论(0)
 

ADORA2A分子别名

ADORA2A,adenosine A2a receptor,A2aR, ADORA2, RDC8

ADORA2A分子背景

This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor (GPCR) superfamily, which is subdivided into classes and subtypes. The receptors are seven-pass transmembrane proteins that respond to extracellular cues and activate intracellular signal transduction pathways. This protein, an adenosine receptor of A2A subtype, uses adenosine as the preferred endogenous agonist and preferentially interacts with the G(s) and G(olf) family of G proteins to increase intracellular cAMP levels. It plays an important role in many biological functions, such as cardiac rhythm and circulation, cerebral and renal blood flow, immune function, pain regulation, and sleep. It has been implicated in pathophysiological conditions such as inflammatory diseases and neurodegenerative disorders. Alternative splicing results in multiple transcript variants. A read-through transcript composed of the upstream SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) gene sequence has been identified, but it is thought to be non-coding.

ADORA2A上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

ADORA2A临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定